Capricor Therapeutics Inc (CAPR)

Apr 21, 2025

Capricor Therapeutics Inc (CAPR) Q4 2024 Earnings Call Highlights: Navigating Financial ... - Yahoo Finance

Apr 21, 2025

Apr 21, 2025

Capricor Therapeutics Inc (CAPR) Q4 2024 Earnings Call Highlights: Navigating Financial Challenges and Strategic Advancements - GuruFocus

Apr 21, 2025

Apr 20, 2025

Analysts Expect Breakeven For Capricor Therapeutics, Inc. (NASDAQ:CAPR) Before Long - simplywall.st

Apr 20, 2025

Apr 17, 2025

uniQure, Hertz Global, Eli Lilly And Other Big Stocks Moving Higher On Thursday - Benzinga

Apr 17, 2025

Apr 17, 2025

When Will Capricor Therapeutics, Inc. (NASDAQ:CAPR) Become Profitable? - Yahoo Finance

Apr 17, 2025

Apr 05, 2025

(CAPR) Trading Advice - news.stocktradersdaily.com

Apr 05, 2025

Apr 01, 2025

Capricor Therapeutics to Present at the 2025 Piper Sandler Virtual Cardio Day - The Manila Times

Apr 01, 2025

Apr 01, 2025

Promising DMD Treatment Update: Capricor CEO Reveals Latest Development Progress - Stock Titan

Apr 01, 2025

Mar 31, 2025

Capricor Therapeutics Plunges 19.91% Amid Clinical Trials Focus - AInvest

Mar 31, 2025

Mar 31, 2025

Robinhood, Couchbase And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Mar 31, 2025

Mar 29, 2025

New Forecasts: Here's What Analysts Think The Future Holds For Capricor Therapeutics, Inc. (NASDAQ:CAPR) - simplywall.st

Mar 29, 2025

Mar 27, 2025

Check Out What Whales Are Doing With CAPR - Benzinga

Mar 27, 2025

Mar 27, 2025

High Growth Tech Stocks In The US Market With Promising Potential - simplywall.st

Mar 27, 2025

Mar 26, 2025

(CAPR) Trading Signals - Stock Traders Daily

Mar 26, 2025

Mar 23, 2025

Capricor projects FDA priority review decision for deramiocel by August 2025 - MSN

Mar 23, 2025

Mar 23, 2025

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 23, 2025

Mar 21, 2025

Capricor Therapeutics’ Earnings Call Highlights Progress and Challenges - TipRanks

Mar 21, 2025

Mar 21, 2025

Capricor Therapeutics Inc (CAPR) Q4 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus

Mar 21, 2025

Mar 21, 2025

Capricor Therapeutics Full Year 2024 Earnings: Beats Expectations - Yahoo Finance

Mar 21, 2025

Mar 20, 2025

Is Capricor Therapeutics (CAPR) a Worst High-Risk High-Reward Growth Stock to Buy? - Insider Monkey

Mar 20, 2025

Mar 20, 2025

Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big Stocks Moving Higher On Thursday - Benzinga

Mar 20, 2025

Mar 20, 2025

Cantor Fitzgerald maintains $30 target on Capricor stock By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

Cantor Fitzgerald maintains $30 target on Capricor stock - Investing.com

Mar 20, 2025

Mar 20, 2025

A Glimpse Into The Expert Outlook On Capricor Therapeutics Through 4 Analysts - Benzinga

Mar 20, 2025

Mar 20, 2025

Capricor Therapeutics Stock (CAPR) Surges on Q4 Results and Promising New Therapy - The Globe and Mail

Mar 20, 2025

Mar 19, 2025

Capricor Therapeutics Reports 2024 Financial Results - TipRanks

Mar 19, 2025

Mar 19, 2025

Capricor: Q4 Earnings Snapshot - mySA

Mar 19, 2025

Mar 19, 2025

Earnings call transcript: Capricor Q4 2024 beats EPS forecast, stock up - Investing.com Canada

Mar 19, 2025

Mar 19, 2025

Capricor Therapeutics (CAPR) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mar 19, 2025

Mar 19, 2025

Capricor Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 19, 2025

Mar 19, 2025

Capricor Therapeutics Inc Reports Q4 2024 Earnings: EPS Loss of - GuruFocus

Mar 19, 2025

Mar 19, 2025

Capricor Therapeutics Q4 Loss Widens, Revenue Decreases - MarketScreener

Mar 19, 2025

Mar 19, 2025

Capricor Therapeutics beats Q4 estimates, shares rise on FDA acceptance By Investing.com - Investing.com Canada

Mar 19, 2025

Mar 19, 2025

Capricor Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView

Mar 19, 2025

Mar 19, 2025

Capricor Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Mar 19, 2025

Mar 19, 2025

Capricor's DMD Breakthrough: FDA Fast-Tracks Novel Therapy as Cash Position Hits $151.5M - StockTitan

Mar 19, 2025

Mar 19, 2025

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely - simplywall.st

Mar 19, 2025

Mar 19, 2025

While institutions own 38% of Capricor Therapeutics, Inc. (NASDAQ:CAPR), retail investors are its largest shareholders with 49% ownership - Yahoo Finance

Mar 19, 2025

Mar 18, 2025

Capricor Therapeutics announces long-term data from HOPE-2 OLE study - Yahoo Finance

Mar 18, 2025

Mar 18, 2025

H.C. Wainwright maintains Capricor stock Buy rating and $77 target By Investing.com - Investing.com UK

Mar 18, 2025

Mar 18, 2025

Capricor Therapeutics’ (CAPR) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Mar 18, 2025

Mar 17, 2025

CAPRICOR THERAPEUTICS Earnings Preview: Recent $CAPR Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 17, 2025

Mar 17, 2025

Capricor Therapeutics Announces Positive Data Demonstrating - GlobeNewswire

Mar 17, 2025

Mar 17, 2025

Capricor reports promising DMD treatment results - Investing.com

Mar 17, 2025

Mar 17, 2025

Capricor Therapeutics Says 3-Year Data Show Deramiocel Slows Duchenne Muscular Dystrophy - Marketscreener.com

Mar 17, 2025

Mar 17, 2025

Capricor reports promising DMD treatment results By Investing.com - Investing.com Australia

Mar 17, 2025

Mar 17, 2025

Capricor Therapeutics Reports 52% Slowing of Duchenne Muscular Dystrophy Disease Progression with Deramiocel in 3-Year Study Presentation at MDA Conference - Nasdaq

Mar 17, 2025